Hong Kong Stock Market News | Lai Kai Pharmaceuticals-B (02105) rose more than 22%, hitting a new high for the year. Recently announced clinical cooperation with eli lilly and co on a new type of weight loss drug.

The stock price of Lai Kai Pharmaceutical-B (02105) rose by over 22%, reaching a high of HK$17.4, setting a new high for the year. As of the time of publication, it has increased by 22.48%, trading at HK$17, with a turnover of 0.178 billion Hong Kong dollars.

Zhitong Finance21:14 ET

Eli Lilly's (LLY) Breakthroughs: Hedge Funds' New Healthcare Favorite

Yahoo Finance14:22 ET

Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'

Yahoo FinanceNov 23 08:27 ET

Trump Nominates Marty Makary For FDA Commissioner

Barron'sNov 22 22:27 ET

The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's

Barron'sNov 22 21:30 ET · Ratings

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 22 21:25 ET